Abstract
Effective public response to a pandemic relies upon accurate measurement of the extent and dynamics of an outbreak. Viral genome sequencing has emerged as a powerful approach to link seemingly unrelated cases, and large-scale sequencing surveillance can inform on critical epidemiological parameters. Here, we report the analysis of 864 SARS-CoV-2 sequences from cases in the New York City metropolitan area during the COVID-19 outbreak in Spring 2020. The majority of cases had no recent travel history or known exposure, and genetically linked cases were spread throughout the region. Comparison to global viral sequences showed that early transmission was most linked to cases from Europe. Our data are consistent with numerous seeds from multiple sources and a prolonged period of unrecognized community spreading. This work highlights the complementary role of genomic surveillance in addition to traditional epidemiological indicators.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially funded by NIH grants R35GM119703 (M.T.M.), P50CA016087 (I.O. and J.G.), P30CA016087 (I.O., P.C., and A.H.), UM1AI148574 (M.J.M), the NYULH Office for Science and Research, and MR/R015600/1 from the MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London (M-R.C., E.M.V.)
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Raw sequencing reads filtered to remove the host genome are available from NCBI SRA under BioProject PRJNA650245. Sequences have been deposited into the GISAID repository immediately upon QC with virus name "NYUMC" and can be visualized at http://nextstrain.org/ncov.
